Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis

Clinical trial NCT00635089 · COMPLETED

Trial details

NCT number: NCT00635089
Sponsor: Ception Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Eosinophilic Esophagitis

Start date: 2008-07-01
Primary completion: 2012-01-01
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.